Niyatee Pradeep Samudra

Niyatee Samudra practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Niyatee Samudra's NPI, 1710373360, was assigned on April 10, 2015. Niyatee Samudra graduated from UT Southwestern Medical Center in 2015. Niyatee Samudra holds California license A170707.

Niyatee Samudra's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Niyatee Samudra's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Niyatee Samudra is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is UCSF Medical Group. Dmand AI also links Niyatee Samudra to 1 more hospital and 3 medical groups, each named with a free account. Niyatee Samudra's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Niyatee Samudra practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Niyatee Samudra's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Niyatee Samudra is board certified in epilepsy by the American Board of Psychiatry and Neurology. Niyatee Samudra is licensed in California.

Dmand AI lists epilepsy, non-alzheimer's dementia (chronic) and parkinson's disease among the conditions Niyatee Samudra treats.

CMS data shows 1,004 Medicare services from Niyatee Samudra across 9 procedure codes in 2024, for 341 Medicare patients. Medicare paid $83,569 for them.

CMS counts 341 Medicare patients who saw Niyatee Samudra in 2024. The largest group is 75 to 84, with 158 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Niyatee Samudra's median patient age at 71, with 54% women.

In 2024, Niyatee Samudra wrote 732 Medicare Part D claims for 136 patients. 94% of them were for generic drugs. CMS names the drug for 656 of them, across 18 drugs with 11 or more claims each, at $66,583 in total drug cost. In 2023, CMS named 65 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Niyatee Samudra for performance year 2024, reported as part of a group. Niyatee Samudra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Niyatee Samudra as offering telehealth.

Dmand AI links 15 papers to Niyatee Samudra, published from 2015 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Magnetic Resonance Imaging, Hippocampus and Seizures. Niyatee Samudra has published most often in Epilepsy Behav. Niyatee Samudra's most frequent co-authors are Bassel Abou-Khalil, MD, Joseph M. Aulino, MD and Martin J. Gallagher, MD, PhD.

CMS Open Payments shows 8 general payments to Niyatee Samudra from 2 drug and device companies from 2024 to 2025. Consulting fees make up the largest share, 71% of the total. UCB, Inc. paid the most, $3,982.

Niyatee Samudra graduated from UT Southwestern Medical Center in 2015. Niyatee Samudra is a member of AAN.

Niyatee Samudra is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.